Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to the relevant provisions of the SEBI Listing Regulations, we would like to inform you that the officials of our Company, Supriya Lifescience Limited ('Company') will be interacting with Analysts/Investors on February 2, 2022 via video conference. This is to further inform that the copy of the Investor Presentation has been uploaded on the Stock Exchanges and on the Company's website www.supriyalifescience.com for your information and for the information of your members and the public at large. This information is submitted to you pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. Note: The above date is subject to change. Change may happen due to exigencies on the part of Company or Analyst/Investor/Fund. Request you to kindly take the same on record.
01-02-2022
Bigul

Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to the relevant provisions of the SEBI Listing Regulations, we would like to inform you that the officials of our Company, Supriya Lifescience Limited ('Company') will be interacting with Analysts/Investors on 31st January 2022 via video conference. This is to further inform that the copy of the Investor Presentation has been uploaded on the Stock Exchanges and on the Company's website www.supriyalifescience.com for your information and for the information of your members and the public at large. This information is submitted to you pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. Note: The above date is subject to change. Change may happen due to exigencies on the part of Company or Analyst/Investor/Fund. Request you to kindly take the same on record.
31-01-2022
Bigul

Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

 Pursuant to Regulation 32(6) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 read with Regulation 41(4) of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, we are enclosing herewith Monitoring Agency Report dated January 25, 2022 issued by ICICI Bank Limited, Monitoring Agency, for the quarter ended December 31, 2021 in respect of utilization of proceeds of the of the fresh issue of the IPO of the Company. Kindly take the same on record and acknowledge the receipt.
27-01-2022
Bigul

Supriya Lifescience Ltd - 543434 - Statement Of Deviation Or Variation In The Use Of Proceeds Of The Fresh Issue Of The Initial Public Offer Of The Company

 Pursuant to Regulation 32(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended read with SEBI Circular No. CIR/CFD/CMD1/162/2019 dated December 24, 2019, please find enclosed herewith statement of deviation(s) or variation(s) in utilization of funds raised through Initial Public Offering (IPO) for the quarter ended December 31, 2021 in the prescribed format. Further, we hereby confirm that there is no deviation or variation in the utilisation of IPO proceeds from the objects stated in the prospectus dated December 21, 2021. Kindly take the same on record and acknowledge the receipt.
27-01-2022
Bigul

Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby enclose the transcript of the Earnings call held on Friday, January 21, 2022 at 4.00 P.M. IST to discuss operational and financial performance of the Company for the quarter and nine months ended December 31, 2021 (Q3 of FY 2021-22). This intimation is also being made available on the website of the Company at: https://supriyalifescience.com/investor-relation/ Kindly take the information on record.
25-01-2022
Bigul

Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 With reference to the above captioned subject, please find enclosed newspaper advertisement published in Financial Express (English) and Loksatta (Marathi) on Saturday, January 22, 2022, containing Unaudited Financial Results for the quarter and nine months ended December 31, 2021. You are requested to kindly take the same on record.
25-01-2022
Bigul

Supriya Lifescience Ltd - 543434 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Please find enclosed herewith a duly signed Certificate under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018 received from Link Intime India Private Limited, Registrar and Share Transfer Agent of the Company for the quarter ended December 31, 2021. You are requested to kindly take the same on record.
24-01-2022

Earnings Call for Q3FY22 of Supriya Lifescience

 Conference Call with Supriya Lifescience Management and Analysts on Q3FY22 Performance and Outlook. Listen to the full earnings transcript.
22-01-2022

Market movers: Supriya Lifescience gets reality check; Hikal back in demand after 11 sessions

 Supriya Lifescience plunged over 17 per cent after the company said its profits declined 32 per cent sequential
21-01-2022
Bigul

Supriya Lifescience Ltd - 543434 - Unaudited Financial Results For The Third Quarter And Nine Months Ended On December 31, 2021 (Revised)

 This has reference to our letter dated January 21, 2022 regarding submission of Unaudited Financial Results for the Quarter and nine months ended December 31, 2021 pursuant to regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015. In this connection, we would like to inform that the aforesaid unaudited results submitted to stock exchanges contain clerical error caused inadvertently. Since only the Sr. No. VII & XV contains error, we affirm that there are no other changes in the Statement of Unaudited Financial Results for the for the Quarter and nine months ended December 31, 2021. We sincerely regret the inconvenience caused in this regard. Kindly take revised Unaudited Financial Statement on your records.
21-01-2022
Next Page
Close

Let's Open Free Demat Account